Search research articles
Contact Us
Filters
Showing results (121-130 of 183) with videos related to
Page
of 19
Sort By:
Plos Neglected Tropical Diseases
|
December 21, 2021
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature
Tamara Nordmann, Stefan Schlabe, Torsten Feldt, et al.
The Journal of Infectious Diseases
|
February 16, 2008
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra, Marylyn M Addo, Daniel E Kaufmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 19, 2022
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Aenne Harberts, Golda M Schaub, Darius F Ruether, et al.
Nature Medicine
|
August 7, 2012
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
Manu Rangachari, Chen Zhu, Kaori Sakuishi, et al.
Haematologica
|
June 23, 2022
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
Sibylle C Mellinghoff, Leonie Mayer, Sandra Robrecht, et al.
Blood
|
July 9, 2005
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
Galit Alter, Nickolas Teigen, Benjamin T Davis, et al.
Blood
|
October 2, 2004
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1
Arthur Y Kim, Georg M Lauer, Kei Ouchi, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Infection
|
June 5, 2023
Tecovirimat for the treatment of severe Mpox in Germany
Lennart Hermanussen, Thomas Theo Brehm, Timo Wolf, et al.
Nature Medicine
|
October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 183) with videos related to
Sort By:
Page
of 19
Plos Neglected Tropical Diseases
|
December 21, 2021
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature
Tamara Nordmann, Stefan Schlabe, Torsten Feldt, et al.
The Journal of Infectious Diseases
|
February 16, 2008
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra, Marylyn M Addo, Daniel E Kaufmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 19, 2022
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Aenne Harberts, Golda M Schaub, Darius F Ruether, et al.
Nature Medicine
|
August 7, 2012
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
Manu Rangachari, Chen Zhu, Kaori Sakuishi, et al.
Haematologica
|
June 23, 2022
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
Sibylle C Mellinghoff, Leonie Mayer, Sandra Robrecht, et al.
Blood
|
July 9, 2005
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
Galit Alter, Nickolas Teigen, Benjamin T Davis, et al.
Blood
|
October 2, 2004
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1
Arthur Y Kim, Georg M Lauer, Kei Ouchi, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Infection
|
June 5, 2023
Tecovirimat for the treatment of severe Mpox in Germany
Lennart Hermanussen, Thomas Theo Brehm, Timo Wolf, et al.
Nature Medicine
|
October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Page
of 19